trial

Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)

NCTId NCT03873337
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 34 (actual)
Sponsored by Rutgers, The State University of New Jersey
Primary completion 2022-01-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
34 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2019-04-22
Primary completion
2022-01-10
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
Persistence Targeted Smoking Cessation in SMI (PTSC-S)Nicotine patch

Sponsors

Rutgers, The State University of New JerseyLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator

Investigators

1
Marc L. Steinberg, PH.D.Principal Investigator

Sites

1 total
New Brunswick, United States

Facts & assertions

4 sourced
Enrollment
34
Phase
NA
Primary Completion Date
2022-01-10
Status
COMPLETED
relationships
The graph out of here
drug
Persistence Targeted Smoking Cessation in SMI (PTSC-S)
drug
Nicotine patch
drug
lead_sponsor
Rutgers, The State University of New Jersey
company
collaborator
National Institute on Drug Abuse (NIDA)
company
indication
Tobacco Use
indication
Tobacco Smoking
indication
Tobacco Use Disorder
indication
investigator
Marc L. Steinberg, PH.D.
person